Differences in oral food challenge reaction severity based on increasing age in a pediatric population

Katie Kennedy1, Maria Katerina C Alfaro1, Zachary C Spergel2

  • 1Division of Allergy and Clinical Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Insights

Infants and toddlers experience less severe food allergy reactions during oral food challenges (OFCs) compared to older children. This suggests that early food introduction may be beneficial, and severe reactions are rare in infants under 12 months.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Nutrition
  • Immunology

Background:

  • Food allergy reactions vary in severity, with age being a significant influencing factor.
  • Understanding age-related differences in reaction severity is crucial for managing food allergies.

Purpose of the Study:

  • To compare oral food challenge (OFC) reaction severity in pediatric patients across different age groups, from infancy to adolescence.
  • To utilize objective clinical outcomes and standardized grading tools to assess reaction severity.

Main Methods:

  • A retrospective review of positive OFC results from two major institutions (September 2016 - February 2019).
  • Reaction severity was determined by specific symptoms (cardiovascular, neurologic, respiratory, laryngeal), epinephrine use, and standardized allergy reaction scales.

Main Results:

  • Infants and toddlers exhibited fewer severe symptoms and required less epinephrine during OFCs compared to older children.
  • Increasing age correlated with higher epinephrine requirements and more severe reaction scores.
  • Asthma history and sesame allergy were linked to increased reaction severity.

Conclusions:

  • Younger children (infants and toddlers) generally experience milder OFC reactions than older children, supporting early food introduction.
  • Severe reactions are uncommon in infants under 12 months, questioning the necessity of extensive pre-introduction allergy testing.
  • Standardized tools are valuable for consistently grading reaction severity during OFCs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
48
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58